HUMABODY - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79179556
Serial Number
79179556
Registration Number
5158366
Word Mark
HUMABODY
Status
700 - Registered
Status Date
2017-03-14
Filing Date
2014-12-17
Registration Number
5158366
Registration Date
2017-03-14
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2016-09-20
Attorney Name
Mark Harrison
Law Office Assigned Location Code
L60
Employee Name
POLLACK, ALISON FRIEDB
Statements
Goods and Services
chemicals used in industry and science; chemical test kits for in vitro testing for laboratory research purposes; biochemicals, namely, monoclonal antibodies and antibody fragments all being proteins for in vitro scientific and laboratory research use; biochemicals, namely, monoclonal antibodies and antibody fragments for in vitro scientific and laboratory research use; antibodies and antibody fragments all being protein in raw material form for scientific research purposes; antibody reagents used for the detection of antigens in cell and tissue analysis for scientific and laboratory in vitro diagnostic use; antibodies and antibody fragments all being proteins for industrial use in the discovery, preclinical and clinical development of therapeutic products
Goods and Services
pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; veterinary preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; therapeutic pharmaceutical preparations in the nature of antibodies and antibody fragments for medical and veterinary purposes; antibodies being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; antibody fragments being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; antibody therapeutics in the nature of therapeutic agents for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; medical diagnostic reagents and veterinary diagnostic reagents in the nature of antibodies and antibody fragments; antibodies and antibody fragments being therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases and or use in the manufacture of therapeutic products
Goods and Services
Treatment and transformation of materials for others, namely, the manufacture of chemicals, biologicals, antibodies and antibody fragments; contract manufacturing services in the field of chemicals, biologicals, antibodies and antibody fragments; custom manufacture of therapies using antibodies and antibody fragments
Goods and Services
Scientific and technological services, namely, scientific research, analysis and testing and research and design in the field of chemicals, biologicals, antibodies and antibody fragments; Scientific laboratory services in the field of antibodies and antibody fragments; research in the field of the development of antibodies and antibody fragments; provision of scientific information in the field of antibodies and antibody fragments for medical and veterinary purposes; engineering of antibodies and antibody fragments; scientific services, namely, drug discovery, preclinical and clinical development of therapeutic products; consultancy services relating thereto, namely, consulting in the field of antibody and antibody fragment design
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2016-01-04
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2016-01-04
Primary Code
005
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2016-01-04
Primary Code
040
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2016-01-04
Primary Code
042
Current Trademark Owners
Party Name
Crescendo Biologics Limited
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Limited Company).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Crescendo Biologics Limited
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Limited Company).
Address
Please log in with your Justia account to see this address.
Party Name
Crescendo Biologics Limited
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (Limited Company).
Address
Please log in with your Justia account to see this address.
Party Name
Crescendo Biologics Limited
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (Limited Company).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
MARK HARRISON
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1281026
International Registration Date
2014-12-17
International Publication Date
2015-12-31
International Renewal Date
2024-12-17
Auto Protection Date
2017-06-30
International Status
001 - Request for extension of protection established
International Status Date
2016-01-03
Priority Claimed In
True
Priority Claimed Date
2014-06-25
First Refusal In
True
Trademark Events
Event DateEvent Description
2016-01-03SN ASSIGNED FOR SECT 66A APPL FROM IB
2016-01-04NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2016-01-04ASSIGNED TO EXAMINER
2016-01-05NON-FINAL ACTION WRITTEN
2016-01-06NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2016-01-08APPLICATION FILING RECEIPT MAILED
2016-01-11REFUSAL PROCESSED BY MPU
2016-01-11NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2016-02-01REFUSAL PROCESSED BY IB
2016-07-11TEAS RESPONSE TO OFFICE ACTION RECEIVED
2016-07-11TEAS CHANGE OF CORRESPONDENCE RECEIVED
2016-07-15ASSIGNED TO LIE
2016-07-15CORRESPONDENCE RECEIVED IN LAW OFFICE
2016-07-15TEAS/EMAIL CORRESPONDENCE ENTERED
2016-07-29FINAL REFUSAL WRITTEN
2016-07-29FINAL REFUSAL E-MAILED
2016-07-29NOTIFICATION OF FINAL REFUSAL EMAILED
2016-08-08TEAS REQUEST FOR RECONSIDERATION RECEIVED
2016-08-08CORRESPONDENCE RECEIVED IN LAW OFFICE
2016-08-08TEAS/EMAIL CORRESPONDENCE ENTERED
2016-08-09EXAMINERS AMENDMENT -WRITTEN
2016-08-09EXAMINERS AMENDMENT E-MAILED
2016-08-09NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2016-08-09EXAMINER'S AMENDMENT ENTERED
2016-08-09APPROVED FOR PUB - PRINCIPAL REGISTER
2016-08-17LAW OFFICE PUBLICATION REVIEW COMPLETED
2016-08-31NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2016-08-31NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2016-08-31NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2016-09-20PUBLISHED FOR OPPOSITION
2016-09-20OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2016-10-18EXTENSION OF TIME TO OPPOSE RECEIVED
2016-11-18NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
2017-02-03EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
2017-03-14REGISTERED-PRINCIPAL REGISTER
2017-06-14FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2017-06-22FINAL DISPOSITION PROCESSED
2017-06-22FINAL DISPOSITION NOTICE SENT TO IB
2017-07-14FINAL DECISION TRANSACTION PROCESSED BY IB
2017-12-07NEW REPRESENTATIVE AT IB RECEIVED